Product Information
BENICAR 40 MG TABLET is a brand product labeled by Cosette Pharmaceuticals, Inc., priced at $17.2416 per EA under NDC 00713086230. Its NADAC has been published 179 times since Feb 22, 2023.
FDA first approved this application on Apr 25, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the olmesartan medoxomil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713086230
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/1/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
New Drug (NDA)
FDA Application
NDA021286FDA Approved
4/25/2002
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for BENICAR 40 MG TABLET has been published 179 times since Feb 22, 2023, and over the history we have for it it has risen 46.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.2416 per EA |
|---|---|
| All-time high | $17.2416 (Jul 22, 2026) |
| All-time low | $11.8133 (Feb 22, 2023) |
| 52-week high | $17.2416 |
| 52-week low | $14.2752 |
| Median price | $14.2420 |
| Average price | $13.8530 |
| Largest weekly change | +10.0% (Sep 25, 2024) |
| Weeks tracked | 179 |
| Tracking since | Feb 22, 2023 |
1W
N/A
1M
0.0%
3M
+10.2%
6M
+9.9%
1Y
+20.8%
3Y
+46.0%
5Y
N/A
All
+46.0%
Last surveyed Jul 22, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENICAR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENICAR 40 MG TABLET, manufactured by Cosette Pharmaceuticals, Inc., is $17.2416 per EA (NDC 00713086230), effective Jul 22, 2026.
How has the price of BENICAR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENICAR 40 MG TABLET has risen 46.0%. It has been tracked across 179 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for BENICAR 40 MG TABLET?
Since Feb 22, 2023, the NADAC for BENICAR 40 MG TABLET has ranged from a low of $11.8133 (Feb 22, 2023) to a high of $17.2416 (Jul 22, 2026), with a median of $14.2420 per EA.
Are there cheaper alternatives to BENICAR 40 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 40 MG TAB, is $0.1083 per EA — about 99% below BENICAR 40 MG TABLET.
Who manufactures BENICAR 40 MG TABLET?
BENICAR 40 MG TABLET (NDC 00713086230) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a brand product.